Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Sarcoma · Osteoid Sarcoma · Ewing Sarcoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China
Contact: Study coordinator (Lung-Ji Chang, PhD) · c@szgimi.org · +86 0755-86573763

Study leads

Lung-Ji Chang, PhD
Principal Investigator
Shenzhen Geno-Immune Medical Institute

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Trial of ABSK043, an Oral PD-L1 Inhibitor, in Patients With Angiogenic Sarcomas

Sarcoma

Abroad (travel likely)RecruitingPHASE2

Toronto, Canada

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Neuroblastoma · Sarcoma

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Aurora, United States

Stereotaxic Body Irradiation of Oligometastase in Sarcoma (Stereosarc)

Sarcoma · Radiosurgery

Abroad (travel likely)RecruitingPHASE2

Bordeaux, France · Caen, France

Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?

Sarcoma · Bone Metastases · Proximal Femur Replacement

Abroad (travel likely)Recruiting

Durham, United States